Literature DB >> 10532420

Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors.

T Sawada1, Y Kato, N Sakayori, Y Takekawa, M Kobayashi.   

Abstract

To elucidate the expression of the MDR1 gene products P-glycoprotein (Pgp) in endothelial cells of newly formed blood microvessels in brain tumors, 30 brain tumors were examined by immunohistochemistry using an anti-Pgp monoclonal antibody, JSB-1. Positive reactions for JSB-1 were detected in endothelial cells in newly formed microvessels in all 16 cases of glioma but not in the 4 meningiomas. Although endothelial cells in newly formed microvessels of all 10 metastatic carcinomas showed positive reactions, negative reactions were seen in those of the primary carcinomas. Compared with reactions of the endothelial cells of normal cerebral capillaries, weak reactions were found in the endothelial cells forming glomeruloid proliferation in newly formed microvessels in the eight glioblastomas and at the border of the surrounding cerebral tissue of the metastatic carcinomas. Since the endothelial cells showing glomeruloid proliferation also had a high proliferative cell nuclear antigen labeling index, the present findings demonstrate a negative relationship between positive reactions for Pgp and the proliferative activities of endothelial cells in cerebral capillaries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10532420     DOI: 10.1007/bf02478898

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  13 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.

Authors:  Stephan Fellner; Björn Bauer; David S Miller; Martina Schaffrik; Martina Fankhänel; Thilo Spruss; Günther Bernhardt; Claudia Graeff; Lothar Färber; Harald Gschaidmeier; Armin Buschauer; Gert Fricker
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Intratumoral modeling of gefitinib pharmacokinetics and pharmacodynamics in an orthotopic mouse model of glioblastoma.

Authors:  Jyoti Sharma; Hua Lv; James M Gallo
Journal:  Cancer Res       Date:  2013-06-24       Impact factor: 12.701

Review 4.  Pharmacokinetic considerations in the treatment of CNS tumours.

Authors:  Susannah Motl; Yanli Zhuang; Christopher M Waters; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.

Authors:  Sabine Spiegl-Kreinecker; Johanna Buchroithner; Leonilla Elbling; Elisabeth Steiner; Gabriele Wurm; Angelika Bodenteich; Johannes Fischer; Michael Micksche; Walter Berger
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

Review 6.  Brain endothelial cells as pharmacological targets in brain tumors.

Authors:  Michel Demeule; Anthony Régina; Borhane Annabi; Yanick Bertrand; Michel W Bojanowski; Richard Béliveau
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 7.  Which drug or drug delivery system can change clinical practice for brain tumor therapy?

Authors:  Tali Siegal
Journal:  Neuro Oncol       Date:  2013-03-15       Impact factor: 12.300

Review 8.  The blood-brain barrier: an engineering perspective.

Authors:  Andrew D Wong; Mao Ye; Amanda F Levy; Jeffrey D Rothstein; Dwight E Bergles; Peter C Searson
Journal:  Front Neuroeng       Date:  2013-08-30

9.  In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.

Authors:  Susanna J E Veringa; Dennis Biesmans; Dannis G van Vuurden; Marc H A Jansen; Laurine E Wedekind; Ilona Horsman; Pieter Wesseling; William Peter Vandertop; David P Noske; GertJan J L Kaspers; Esther Hulleman
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

10.  Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system.

Authors:  Elvis Terci Valera; Agda Karina Brodoloni Lucio-Eterovic; Luciano Neder; Carlos Alberto Scrideli; Helio Rubens Machado; Carlos Gilberto Carlotti-Junior; Rosane Gomes de Paula Queiroz; Fabio José do Nascimento Motta; Luiz Gonzaga Tone
Journal:  J Neurooncol       Date:  2007-04-12       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.